Drug intelligence / Profile preview

Lipin-Biolik

Development stage
Unknown
Lead developer
Farmstandart-Biolik
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Inhalation, Intravenous, Oral, Rectal
01

Overview

Lipin-Biolik is a liposomal formulation of lecithin (phosphatidylcholine) developed and manufactured by Farmstandart-Biolik. It is an original membrane-protective, antihypoxic, and antioxidant agent approved in Ukraine. Lipin-Biolik is used as part of complex therapy for a wide range of conditions, including acute and chronic respiratory failure (including respiratory distress syndrome in newborns), acute myocardial infarction, unstable angina, acute and chronic active hepatitis, liver cirrhosis, ulcerative colitis, late gestosis, intra-abdominal fetal hypoxia, placental dysfunction, and various nephropathies (such as pyelonephritis, glomerulonephritis, and diabetic nephropathy). The drug acts by restoring the structural integrity of cell membranes, improving microcirculation, enhancing oxygen diffusion across biological membranes, and supporting the body's antioxidant systems.

Brand names
LipinLipin-Biolik
Other names
lecithinlecithin-standardphosphatidylcholine
02

Targets

PS (Pulmonary surfactant phospholipid layer)

Beyond the preview

Go deeper on Lipin-Biolik.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipin-Biolik.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call